Raltegravir Tablet

Get a Price/Quote

Raltegravir Tablet Specification

Indication
Antiretroviral, HIV Integrase Inhibitor

CAS No
518048-05-0

Dosage Form
Tablet

Assay
Not less than 98% and not more than 102%

Usage
For the treatment of HIV-1 infection

Dosage
400 mg

Molecular Formula
C20H21FN6O5

Storage
Store below 30C in a dry place, protected from light

Medicine Type
Allopathic

Salt Composition
Raltegravir Potassium

Appearance
White to off-white tablet

Pacakaging (Quantity Per Box)
60 Tablets per box

Origin of Medicine
India

Expiration Date
24 to 36 months from manufacturing

Grade
Pharmaceutical Grade

Raltegravir Tablet Trade Information

Minimum Order Quantity
100 bottle

Payment Terms
Letter of Credit (L/C), Paypal, Western Union, Cash in Advance (CID), Cash Advance (CA)

Delivery Time
30 Days

Sample Policy
Within a certain price range free samples are available

Main Export Market(s)
Eastern Europe, Middle East, Africa, Central America, South America, Western Europe, Asia, North America, Australia

Certifications
ISO, GMP, WHO

About Raltegravir Tablet

Raltegravir Tablet

Product Description

Gaining immense appreciation across worldwide market, we are successfully exporting an extensive stock of Raltegravir Tablet. The drug belongs to specific class of medicines of human immunodeficiency virus integrase strand transfer inhibitor. Under the guidance of our expert and highly experienced pharmacists, we procure this Raltegravir Tablet from trusted vendors of market. Before the final delivery, we make sure to inspect the quality of the medicine on various standard parameters.

Key points: